Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Nokia Corporation (NOK), Sears Holdings (SHLD) Citigroup (C): Chou Associates Management’s Top Picks for Q2

Page 1 of 2

Francis Chou’s Chou Associates Management has filed its latest 13F with the SEC, disclosing the positions held in its equity portfolio as of March 31, 2015. Based in Toronto, Canada, Chou Associates had modest returns of 2.7% for Series A units in 2014. That compared unfavorably to the returns of the S&P 500 Total Return Index, which returned 13.7% for the year. However the fund did benefit from the appreciation of the U.S dollar versus the Canadian dollar, with the latter rising by more than 9% against the former. That effectively bumped Chou’s returns to 12.1%. Still, it was a down year for Chou, whose Series A units returned 41.3% and 27.0% in 2013 and 2012 respectively. Chou’s fund utilizes a value-oriented approach to investing that focuses primarily on the long-term strength of the invested company. As the fund has a long-term investment philosophy, there is limited turnover in its portfolio from quarter to quarter, as we’ll see when we take a look at its top picks.

Francis Chou Chou Associates Management

Chou Associates is just one of more than 700 hedge funds that we have in our database as part of our small-cap strategy. Even though most smaller investors consider that tracking 13F filings is a fruitless endeavor because they are filed with a delay of around 45 days after the end of the period of report, the results of our research prove otherwise. To be on the safe side, we used a delay of 60 days in our backtests that involved funds’ 13F filings between 1999 and 2012 and still managed to gain an annual alpha in the double digits. Moreover, since the official launch of our strategy in August 2012, we obtained returns of more than 137%, beating the S&P 500 Total Return Index by some 80 percentage points (see all the details).

Chou’s top pick remains Resolute Forest Products Inc (NYSE:RFP), as his fund maintained its 4.08 million share position in the Canadian-based, global pulp and paper manufacturing company, with operations in Canada, the U.S, and South Korea. The value of Chou’s holding declined slightly during the first quarter to $70.41 million as shares of Resolute Forest Products Inc (NYSE:RFP) dipped by 2.04% during the quarter. That was bad news for another prominent Canadian investor, Prem Watsa of Fairfax Financial, who suffered big Q1 losses due to his large exposure to Resolute Forest Products Inc (NYSE:RFP) and Canadian technology company BlackBerry Ltd (NASDAQ:BBRY). The two companies comprised more than 66% of Watsa’s equity portfolio as of the end of 2014.

Chou’s position in Berkshire Hathaway Inc. (NYSE:BRK.A) also remained unchanged from the previous quarter at 300 shares valued at $65.26 million (yes, that’s over $215,000 per share). The value of those shares was also down from the end of 2014 as they fell by 3.88%. Still, if there’s a safer long-term investment than in Warren Buffett’s Berkshire Hathaway Inc. (NYSE:BRK.A), you’d be hard-pressed to find it. The meteoric rise in value of his holding company and its shares propelled Buffett into the enviable position of second-richest man in the world late in 2014, behind only Microsoft Corporation (NASDAQ:MSFT) founder Bill Gates, though he’s since been overtaken for the position by Carlos Slim. Speaking of Gates, the Bill and Melinda Gates Foundation Trust remained the largest shareholder of Berkshire Hathaway Inc. (NYSE:BRK.A) thanks to a series of donations of shares to the fund by Buffett.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!